nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 antibody in a pancreatic cancer model in vivo
|
Ye, Jie |
|
2017 |
110 |
C |
p. 62-69 |
artikel |
2 |
Calendar of Events
|
|
|
2017 |
110 |
C |
p. I |
artikel |
3 |
Cocrystal solubility product analysis – Dual concentration-pH mass action model not dependent on explicit solubility equations
|
Avdeef, Alex |
|
2017 |
110 |
C |
p. 2-18 |
artikel |
4 |
Development of solid SEDDS, VI: Effect of precoating of Neusilin® US2 with PVP on drug release from adsorbed self-emulsifying lipid-based formulations
|
Gumaste, Suhas G. |
|
2017 |
110 |
C |
p. 124-133 |
artikel |
5 |
Development of solid SEDDS, VII: Effect of pore size of silica on drug release from adsorbed self-emulsifying lipid-based formulations
|
Gumaste, Suhas G. |
|
2017 |
110 |
C |
p. 134-147 |
artikel |
6 |
Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer
|
Li, Xin |
|
2017 |
110 |
C |
p. 51-61 |
artikel |
7 |
Editorial board members
|
|
|
2017 |
110 |
C |
p. IFC |
artikel |
8 |
Editorial, IAPC-5 Special Issue
|
Mandić, Zoran |
|
2017 |
110 |
C |
p. 1 |
artikel |
9 |
Epiberberine, a natural protoberberine alkaloid, inhibits urease of Helicobacter pylori and jack bean: Susceptibility and mechanism
|
Tan, Lihua |
|
2017 |
110 |
C |
p. 77-86 |
artikel |
10 |
Geniposide improves insulin production and reduces apoptosis in high glucose-induced glucotoxic insulinoma cells
|
Guo, L.X. |
|
2017 |
110 |
C |
p. 70-76 |
artikel |
11 |
How to identify and eliminate compounds with a risk of high clinical dose during the early phase of lead optimisation in drug discovery
|
Teague, Simon |
|
2017 |
110 |
C |
p. 37-50 |
artikel |
12 |
Large porous particles for respiratory drug delivery. Glycine-based formulations
|
Ogienko, A.G. |
|
2017 |
110 |
C |
p. 148-156 |
artikel |
13 |
Phenyl butyrate inhibits pyruvate dehydrogenase kinase 1 and contributes to its anti-cancer effect
|
Zhang, Wen |
|
2017 |
110 |
C |
p. 93-100 |
artikel |
14 |
Predictors for drug effects with brain disease: Shed new light from EEG parameters to brain connectomics
|
Tian, Yin |
|
2017 |
110 |
C |
p. 26-36 |
artikel |
15 |
Quantification and modeling of nanomechanical properties of chlorpropamide α, β, and γ conformational polymorphs
|
Janković, Biljana |
|
2017 |
110 |
C |
p. 109-116 |
artikel |
16 |
SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells
|
Wu, Xiaoli |
|
2017 |
110 |
C |
p. 101-108 |
artikel |
17 |
Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells
|
Zhang, Shao-Lin |
|
2017 |
110 |
C |
p. 87-92 |
artikel |
18 |
The indications of tautomeric conversion in amorphous bicalutamide drug
|
Rams-Baron, Marzena |
|
2017 |
110 |
C |
p. 117-123 |
artikel |
19 |
Two novel cocrystals of lamotrigine with isomeric bipyridines and in situ monitoring of the cocrystallization
|
Du, Shichao |
|
2017 |
110 |
C |
p. 19-25 |
artikel |